66
Participants
Start Date
February 28, 2011
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
Latanoprost 0.005%
q.d.
AR-12286 Ophthalmic Solution 0.5%
Timolol maleate ophthalmic solution 0.5%
Glaucoma Consultants of the Capital Region, Slingerlands
Rochester Ophthalmology Group, Rochester
Wills Eye Hospital, Philadelphia
Alan L Robin, M.D., Baltimore
Thomas K. Mundorf, M.D., Charlotte
Charlotte Eye Ear Nose and Throat, Charlotte
Coastal Research Associates, LLC, Roswell
Taustine Eye Center, Louisville
Black Hills Regional Eye Institute, Rapid City
Comprehensive Eye Care, St Louis
Heart of America Eye Care, P.A., Shawnee Mission
The Eye Institute, Tulsa
Cataract & Glaucoma Center, El Paso
Stacy R. Smith, M.D., Salt Lake City
David Silverstone, M.D., New Haven
Lead Sponsor
Aerie Pharmaceuticals
INDUSTRY